{"id":"NCT00552279","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age","officialTitle":"Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 Administered According to an Alternative Dosing Schedule as Compared to the Standard Dosing Schedule in Young Female Subjects Aged 15-25 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11-12","primaryCompletion":"2009-02-26","completion":"2009-07-20","firstPosted":"2007-11-01","resultsPosted":"2010-03-05","lastUpdate":"2018-06-25"},"enrollment":805,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus"],"interventions":[{"type":"BIOLOGICAL","name":"Cervarix TM","otherNames":["HPV vaccine (GSK580299)"]},{"type":"BIOLOGICAL","name":"Cervarix TM","otherNames":[]}],"arms":[{"label":"Cervarix-12 Group","type":"EXPERIMENTAL"},{"label":"Cervarix-6 Group","type":"ACTIVE_COMPARATOR"}],"summary":"Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current phase 3b study is designed to assess the immunogenicity and safety of GlaxoSmithKline Biologicals' HPV vaccine GSK580299 administered according to an alternative dosing schedule as compared to the standard dosing schedule in young female subjects aged 15 - 25 years. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Subjects Seroconverted for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies","timeFrame":"One month after the third vaccine dose","effectByArm":[{"arm":"Cervarix-12 Group","deltaMin":337,"sd":null},{"arm":"Cervarix-6 Group","deltaMin":342,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":15},"locations":{"siteCount":16,"countries":["Italy","Romania","Slovakia"]},"refs":{"pmids":["21273939"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":403},"commonTop":["Pain","Fatigue","Headache","Redness","Myalgia"]}}